Abstract:A series of novel matrine-dithiocarbamate (DTC) hybrids were efficiently synthesised from matrine through a three-step sequence involving basic hydrolysis, esterification, and DTC formation. They were evaluated for their in vitro cytotoxic potency on several human cancer and normal cells. All matrine-DTC hybrids were much more toxic against the human hepatoma cell line HepG2 than the parent matrine. Hybrid 4l (IC 50 = 31.39 μM) was the most potent compound against HepG2 cells, being 156- and 3-fold more toxic than matrine (IC 50 > 4900 μM) and the reference vincristine (VCR, IC 50 = 93.67 μM), respectively. Moreover, hybrid 4l was less toxic to normal human embryonic kidney cell line HEK-293T, with a higher selectivity index (SI, HEK-293T/HepG2 ≈ 6) than matrine (SI ≈ 1) and VCR (SI ≈ 1). The structure-activity relationship analysis indicated that selectivity was greatly boosted when 4-(trifluoromethyl)benzyl was incorporated into the hybrids ( 4f and 4l ). In addition, the hybrid 4l was also highly toxic to the other five types of human cancer cells (Calu-1, SK-BR-3, HUH-7, 786-O and SK-OV-3; IC 50 = 44.18–112.19 μM), whereas it was relatively less toxic to the corresponding normal cells (WI-38, LX-2, HEK-293T and KGN; IC 50 = 81.48–195.17 μM). Further mechanistic studies showed that hybrid 4l induced apoptosis in a concentration-dependent manner in HepG2 cells. Our results demonstrate that the cytotoxic activity of matrine can be highly enhanced by hybridisation with DTC. Hybrid 4l has promising applications in anticancer drug development.

Synthesis, Biological Evaluation and Mechanism Studies of Matrine Derivatives As Anticancer Agents.

Synthesis, Characterization And Activity Evaluation Of Matrinic Acid Derivatives As Potential Antiproliferative Agents

Design, Synthesis and Biological Evaluation of Matrine Derivatives As Potential Anticancer Agents.

Synthesis and Biological Evaluation of Matrine Derivatives As Anti-Hepatocellular Cancer Agents.

Synthesis, Characterization and in Vitro Anti-Tumor Activities of Matrine Derivatives

Design, Synthesis, and In vitro Biological Activities of Matrine Skeleton Derivatives as Potential Cancer Inhibitors

Synthesis and Biological Evaluation of the Matrine Derivatives As a Novel Family of Potential Anticancer Agents

Synthesis, Biological activities, and Molecular docking Studies of 15‐site Matrine Based Isatohydrazone Derivatives as Potential Anticancer Agents

Synthesis of Novel Matrine Derivatives Containing Furanone Skeleton and Preliminary Evaluation of Their Anticancer Activity in Vitro

Synthesis and biological evaluation of matrine derivatives containing benzo-α-pyrone structure as potent anti-lung cancer agents

Design, Synthesis and Anticancer Activity of Matrine Derivatives with Spiro

Synthesis, characterization and in vitro biological evaluation of two matrine derivatives

Synthesis and Biological Evaluation of Nitric Oxide-Releasing Matrine Derivatives As Anticancer Agents

Synthesis and antitumor activity of 13-acylmatrine derivatives

Synthesis and Biological Evaluation of Novel Hybrid Matrine Derivatives As Anticancer Agents

Design, Synthesis, and Biological Evaluation of Matrine Derivatives Possessing Piperazine Moiety As Antitumor Agents

Synthesis and Anti-Tumor Activity Evaluation of Matijin-Su Derivatives.

Synthesis and Anti-cancer Activity of Nitric Oxide Donor-based Matrine Derivatives

Matrine Reduces Proliferation of Human Lung Cancer Cells by Inducing Apoptosis and Changing Mirna Expression Profiles

Design, synthesis and biological evaluation of matrine-dithiocarbamate hybrids as potential anticancer agents

Synthesis and biological evaluation of novel Jiyuan Oridonin A-1,2,3-triazole-azole derivatives as antiproliferative agents.